Dynavax Technologies | DVAX - EPS Earnings Per Share

Stock Price
15.51
Daily Change
0.03 0.19%
Monthly
0.65%
Yearly
17.86%
Q1 Forecast
15.01

Dynavax Technologies reported $0.21 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 0.04 0.05 Feb/19 2026
FY2025Q3 Sep/2025 0.21 0.13 0.12 Nov/05 2025
FY2025Q2 Jun/2025 0.14 0.10 0.08 Aug/07 2025
FY2025Q1 Mar/2025 -0.77 0.01 -0.07 May/06 2025
FY2024Q4 Dec/2024 0.05 0.04 0.0 Feb/20 2025




Eps Change Date
AbbVie USD 2.71 0.85 Dec/2025
Adma Biologics USD 0.15 0.01 Sep/2025
Amgen USD 5.29 0.35 Dec/2025
AstraZeneca USD 2.38 0.21 Sep/2025
Biogen USD 4.81 0.66 Sep/2025
BioMarin Pharmaceutical USD 0.12 1.32 Sep/2025
Bristol-Myers Squibb USD 1.63 0.17 Sep/2025
Dynavax Technologies USD 0.21 0.07 Sep/2025
Gilead Sciences USD 2.47 0.46 Sep/2025
Glaxosmithkline GBP 0.72 0.37 Sep/2025
Merck USD 2.04 0.54 Dec/2025
Neurocrine Biosciences USD 2.17 0.52 Sep/2025
Novartis USD 2.04 0.38 Sep/2025
Pfizer USD 0.66 0.21 Dec/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025
Sarepta Therapeutics USD -0.13 2.15 Sep/2025
TG Therapeutics USD 2.43 2.26 Sep/2025
Vertex Pharmaceuticals USD 4.8 0.28 Sep/2025